Medical coding in clinical trials converts free-text clinical data — such as adverse events, medical histories, procedures, and medications — into standardized terminology using international dictionaries.
Purpose: Standardization enables researchers to analyze, compare, and report clinical data consistently across global study sites while supporting regulatory submissions and safety monitoring.
Key Dictionaries:
- MedDRA (Medical Dictionary for Regulatory Activities): Codes adverse events, symptoms, and medical conditions.
- WHODrug Dictionary: Codes medications, active ingredients, and drug classifications.
Why It Matters: Accurate coding ensures reliable clinical datasets, allowing researchers and regulators to interpret trial results consistently and identify safety signals or trends.
Common Challenges: Inconsistent investigator terminology, ambiguous descriptions, and periodic dictionary updates can introduce coding variability.
Best Practices: Clear coding guidelines, integrated clinical data management systems, and ongoing quality control help maintain accuracy, regulatory compliance, and overall data integrity throughout the trial lifecycle.
Medical coding is a foundational component of clinical data management, as it standardizes clinical terminology across trials globally. It’s the practice of transforming raw clinical data, such as adverse events, into structured terminology — typically with the help of standardized dictionaries like the Medical Dictionary for Regulatory Activities (MedDRA) and the WHODrug Dictionary — so researchers and professionals worldwide can understand it.
Accurate medical coding is essential to many aspects of clinical trials, including regulatory submissions, safety monitoring, and reliable analysis. Without it, the world of clinical trials might look much different and function less effectively than it does today. Everyone involved in clinical research can benefit from learning more about how medical coding works and the vital role it plays in clinical testing and trials.
What Is Medical Coding in Clinical Trials?
In the context of clinical research, medical coding is the process of converting free-text data into structured data for universal understanding. Structured data typically takes the form of an alphanumeric code found in standardized coding dictionaries, such as MedDRA or the WHODrug Dictionary. This kind of medical coding differs significantly from that used in healthcare settings, which primarily ensures appropriate billing and insurance claims for the services that patients receive from their providers.
The purpose of clinical trial coding is to standardize verbatim clinical data collected during studies. Types of data that are commonly coded include:
- Adverse events reported by patients or investigators, such as a new or worsening symptom or abnormal test result.
- Concomitant medications that were used during the trial to observe any interactions between drugs and see how or if they affected the study results.
- The medical histories or prior conditions of the trial subjects, particularly if they might provide relevant or useful context for the study.
- Any procedures undergone by or diagnoses given to subjects during the course of the study.
Medical coding enables researchers to more easily compare information gathered from clinical trial subjects and analyze and report those findings in finalized studies.
Why Medical Coding Is Critical for Clinical Trial Data Integrity
Beyond being essential for the functioning of clinical research, medical coding directly impacts other crucial areas of trials. This includes researchers’ ability to monitor patient safety effectively, comply with official regulations, and maintain the integrity of the trial data.
Standardizing terminology used in clinical trials yields clear, easily understood, consistently interpreted, comparable, and analyzable data. It means that multiple researchers can engage with the findings of a clinical trial, no matter where in the world they’re based, and review the same information with confidence.
Without standardization, both current and future researchers may struggle to glean useful insights from clinical trial data. It’s important to ensure quality throughout the coding process to protect data integrity and maximize the benefit that could come from any given clinical trial.
Common Coding Dictionaries Used in Clinical Trials
Clinical trials require the use of medical coding dictionaries to standardize and classify clinical data. The two main dictionaries used are MedDRA and the WHODrug Dictionary. Each serves a distinct purpose in coding clinical trials.
MedDRA (Medical Dictionary for Regulatory Activities)
MedDRA is the dictionary used for coding adverse events and medical conditions in clinical trials, particularly in the medical device and pharmaceutical industries. It’s highly hierarchical, allowing researchers to analyze data at different levels of detail best suited to their needs.
There are five levels of MedDRA terminology:
- Lowest Level Term (LLT): The most specific term that usually reflects how information is reported, including lexical variants and synonyms that roll up to a single preferred term (PT).
- Preferred Term (PT): A specific descriptor for a given term, disease, symptom, experience, device, or procedure. A single PT will encompass multiple LLTs to account for variations and synonyms describing a similar concept.
- High Level Term (HLT): A more umbrella descriptor that groups similar or related PTs, such as those that share a common pathology, anatomy, or function.
- High Level Group Term (HLGT): An even larger umbrella descriptor that groups similar or related HLTs into a single class.
- System Organ Class (SOC): The broadest and most general classifier that groups similar HLGTs based on aetiology, purpose, or location in the body.
Different terms are then assigned an eight-digit number for coding purposes. There can be some ambiguity related to verbatim quality and term-selection decisions. This can lead to coding inconsistencies, especially if coding quality is a priority from the outset. However, the current structure allows for an impressive level of detail and specificity through clinical development and post-marketing safe activities.
WHODrug Dictionary
The WHODrug Dictionary is the other major resource used for medical coding in clinical trials. It primarily focuses on coding concomitant medications, drug exposures, and interactions. This dictionary helps standardize the coding of medication names, their active ingredients, and therapeutic functions. It covers prescription drugs, over-the-counter medicines, and even herbal remedies from nearly 150 countries.
This dictionary is essential to ensuring the safety of patients and subjects in clinical trials. The classification system can make it easier for researchers to identify and report any drug-related issues. It can also reduce errors in the use of medication names and promote consistency across global markets.
If there are any errors, however, it can be time-consuming to review and fix incorrect drug names manually. The WHODrug Dictionary is also frequently revised as new drugs are released and new information about existing medications or interactions becomes available. This requires researchers to stay up to date with the latest version of the dictionary to ensure the highest quality and most accurate coding.
Common Challenges in Medical Coding
It may provide many benefits, but in clinical trials, medical coding also presents significant challenges. Despite the emphasis on standardization, medical coding still requires careful interpretation of clinical terminology and consistency across the entire process. Some of the biggest challenges hindering medical coding efforts include:
- Inconsistent term use: Investigators may not enter verbatim terms consistently and accidentally use variations or synonyms instead of the exact words. This can lead researchers to use incorrect or inconsistent codes when translating the terms, thereby impacting data quality.
- Ambiguous descriptions: Clinical descriptions may be ambiguous or difficult to discern without further clarification. This can cause researchers to interpret and code findings differently, leading to inconsistencies across the data.
- Dictionary updates: Both MedDRA and the WHODrug Dictionary are updated twice per year to reflect real-world changes and developments. Sponsors should prespecify a dictionary versioning strategy and manage updates consistently, especially for pooled analysis and submissions.
Ultimately, addressing these challenges is essential to maintain clean, analyzable clinical datasets. One small mistake may not seem like much, but these issues can overlap and multiply, resulting in bigger problems with data integrity if left unchecked.
Best Practices for Accurate Medical Coding in Clinical Trials
There are several best practices that researchers can follow when coding to overcome the challenges above. Following the processes below keeps quality at the forefront, helping with both data integrity and regulatory readiness.
Establish Clear Coding Guidelines
Before any research begins, it’s important to establish clear coding guidelines. These guidelines should define coding conventions and escalation procedures before trial initiation, so that researchers can adhere to them throughout the project. They should also address what to do in the event of unique circumstances, such as when a coding dictionary is updated mid-trial.
Standardizing coding guidelines can help ensure a consistent approach to the project across the entire coding team. They can reduce ambiguity and error while equipping coders with the knowledge they need to do their jobs quickly without sacrificing quality.
Use Unified Clinical Data Management Systems
Modern researchers can — and should — take advantage of modern technology to further improve the medical coding process. Certain clinical data management platforms natively support medical coding tools to streamline workflows. With a high-quality electronic data capture system, it’s far easier for researchers to gather, review, and analyze their clinical data.
Beyond this, integrated clinical data management systems can be beneficial for adhering to relevant study regulations. Automated coding suggestions and audit trails not only improve efficiency but also traceability. The right eClinical solution should also offer benefits such as fast performance and a streamlined import process, so the platform is intuitive and easy for research teams to use to its full potential.
Maintain Ongoing Quality Control
Quality needs to be top of mind when doing medical coding in clinical trials. That doesn’t just mean prioritizing quality in medical coding, but also conducting routine quality checks at various stages throughout the study.
Having periodic reviews and dedicated quality control of coding work can help to spot issues and detect inconsistencies early in the process. These mistakes can be corrected before getting too far into the study, meaning they require less work to fix and don’t create additional problems down the line. Ideally, quality control should be an ongoing process throughout the trial, ensuring data quality at every turn.
Between adhering to regulations and consistently using the correct codes, medical coding in clinical trials can be complicated and challenging. However, it’s vital to do so properly to protect the integrity of the study and its findings.
The right clinical research software can help overcome the difficulties of medical coding in trials while safeguarding the quality of study data. Check out TrialKit, the award-winning eClinical platform from Crucial Data Solutions, to revolutionize the management of your next study.
FAQs About Medical Coding in Clinical Trials
What is medical coding in clinical trials?
Medical coding in clinical trials is the process of translating clinical information—such as adverse events, medications, and medical histories—into standardized terminology using recognized dictionaries like MedDRA and the WHODrug Dictionary. This standardization allows clinical data to be analyzed consistently across study sites and ensures that safety information can be accurately reported to regulatory agencies.
Why is medical coding important in clinical trials?
Medical coding ensures that clinical trial data is standardized, interpretable, and compliant with regulatory expectations. Accurate coding allows safety teams to identify trends in adverse events, supports reliable statistical analysis, and ensures that regulatory agencies can review trial results efficiently during the drug approval process.
What dictionaries are used for medical coding in clinical trials?
Two of the most commonly used coding dictionaries are MedDRA and the WHODrug Dictionary. MedDRA is used to code adverse events, medical conditions, and clinical symptoms, while the WHODrug Dictionary standardizes medication names and drug classifications. Together, these systems ensure consistent classification of medical data across clinical studies.
Who performs medical coding in clinical trials?
Medical coding is typically performed by trained medical coders or clinical data management professionals. These specialists review investigator-reported verbatim terms and map them to standardized terminology using coding dictionaries. Coders often work closely with data managers and safety teams to resolve ambiguities and ensure coding accuracy.
What challenges are common in clinical trial medical coding?
Common challenges include inconsistent investigator terminology, ambiguous verbatim entries, dictionary version updates, and the need to harmonize coded data across multiple studies. Addressing these challenges requires structured coding guidelines, experienced coders, and integrated clinical data management systems that support accurate and traceable coding workflows.
